Normalized protein catabolic rate and lymphopenia drive humoral response to the Pfizer BNT162b2 vaccine in haemodialysis patients.

Jacq, Amélie; Rebibou, Jean-Michel; Kohler, Emmanuelle; Baudoin, Charline; Bour, Jean-Baptiste; De Rougemont, Alexis; Marechal, Elise; Legendre, Mathieu

Jacq, Amélie; Rebibou, Jean-Michel; Kohler, Emmanuelle; Baudoin, Charline; Bour, Jean-Baptiste; De Rougemont, Alexis; Marechal, Elise; Legendre, Mathieu.

Afiliação

Jacq A; Faculté de Médecine et de Pharmacie, University of Bourgogne Franche-Comté, Dijon, France.
Rebibou JM; Department of Nephrology, University of Bourgogne Franche-Comté, CHU Dijon, France.
Kohler E; Faculté de Médecine et de Pharmacie, University of Bourgogne Franche-Comté, Dijon, France.
Baudoin C; Department of Nephrology, University of Bourgogne Franche-Comté, CHU Dijon, France.
Bour JB; INSERM, UMR 1098 Federation Hospitalo-Universitaire, INCREASE, Besançon, France.
De Rougemont A; Department of Nephrology, University of Bourgogne Franche-Comté, CHU Dijon, France.
Marechal E; Faculté de Médecine et de Pharmacie, University of Bourgogne Franche-Comté, Dijon, France.
Legendre M; Department of Nephrology, University of Bourgogne Franche-Comté, CHU Dijon, France.

Nephrol Dial Transplant ; 36(11): 2140-2142, 2021 11 09.

Article em En | MEDLINE | ID: mdl-34383943

Assuntos

Linfopenia; Vacinas; Vacina BNT162; Vacinas contra COVID-19; Humanos; Linfopenia/etiologia; Diálise Renal/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Linfopenia Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Nephrol Dial Transplant Assunto da revista: NEFROLOGIA / TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google